Traszeptin 440mg

Oncologists prescribe it for HER2 positive breast cancer and metastatic stomach cancer, given as a vein infusion.

Traszeptin 440mg Injection Ingredients and Usage

Traszeptin 440mg Injection contains trastuzumab, a humanized monoclonal antibody that targets the HER2 protein on cancer cells. A monoclonal antibody is a lab made protein that locks onto one specific target inside the body. Trastuzumab belongs to the HER2 targeted therapy class rather than standard cytotoxic chemotherapy.

Traszeptin treats HER2 positive breast cancer in both early stage and advanced disease, alone or with chemotherapy. It also treats metastatic stomach and gastroesophageal junction cancer that overproduces the HER2 protein. Doctors confirm HER2 status with a lab test before starting Traszeptin, since the drug only helps HER2 positive tumours.

How Does Traszeptin 440mg Injection Work?

Traszeptin 440mg Injection works because trastuzumab binds the outer domain of HER2, a growth receptor on the surface of some cancer cells. HER2 is human epidermal growth factor receptor 2, a protein that drives rapid tumour growth when overproduced. Trastuzumab blocks these growth signals, which slows or stops cancer cell division.

Trastuzumab also flags the cancer cell for destruction by the immune system, a process called antibody dependent cellular cytotoxicity. HER2 is overproduced in roughly 25 to 30 percent of breast cancers, which makes it a precise treatment target. This dual action shrinks tumours and slows the spread of HER2 positive cancer.

Traszeptin 440mg Injection Side Effects

Traszeptin 440mg Injection commonly causes infusion related and general symptoms, especially during the first dose. Report fever, breathlessness, or swelling to your care team without delay.

• Infusion reactions such as fever, chills, and shivering

• Reduced heart pumping strength

• Nausea and vomiting

• Diarrhoea

• Fatigue and weakness

• Headache

• Higher risk of infection

• Skin rash

Warnings

• Trastuzumab can weaken the heart muscle and cause heart failure, so doctors check heart function before and during treatment.

• Severe infusion reactions and lung toxicity can occur, and these reactions are sometimes fatal.

• Trastuzumab harms the unborn baby, so females of reproductive age must use effective contraception during treatment and for seven months after.

• Doctors must confirm HER2 positive status with a validated test before starting Traszeptin.

• Patients with severe breathing problems or those needing oxygen therapy face a higher risk of serious reactions.

• Combining trastuzumab with anthracycline chemotherapy raises the risk of heart damage.

Traszeptin 440mg Injection Storage Conditions

Store Traszeptin 440mg Injection in a refrigerator between 2°C and 8°C, and never freeze the vial. Keep the vial in its original carton to protect the trastuzumab powder from light until a pharmacist reconstitutes it. After mixing with the supplied diluent, the solution stays stable for up to 28 days when refrigerated between 2°C and 8°C.